Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ovarian Cycle01:27

Ovarian Cycle

1.5K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.5K
Oogenesis02:07

Oogenesis

63.9K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.9K
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

435
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
435
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

774
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
774
Infertility in Females01:28

Infertility in Females

368
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
368
Ovaries01:26

Ovaries

1.1K
The ovaries are roughly the size of almonds and measure approximately 2 to 3 centimeters in length. These paired structures are situated within the pelvic region and are anchored by the mesovarium—a peritoneal extension that also connects them to the wider structure of the broad ligament. The support system extends to the suspensory ligament, housing blood and lymphatic vessels. In addition, the ovarian ligament tethers the ovaries to the uterus.
On the ovarian surface, a layer of...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Cross-Sectional Survey of Women's Health Knowledge and Care Provision in a Large Primary Care Health System.

Journal of general internal medicine·2025
Same author

Directory of Internal Medicine Residency and Fellowship Programs in Women's Health, 2022.

Journal of women's health (2002)·2022
Same author

Interprofessional Leadership Development: Role of Emotional Intelligence and Communication Skills Training.

MedEdPORTAL : the journal of teaching and learning resources·2022
Same author

Review of the Medical Student Performance Evaluation: analysis of the end-users' perspective across the specialties.

Medical education online·2021
Same author

Integrating Women's Health Education into the Internal Medicine Residency Program Curriculum.

Southern medical journal·2021
Same author

Lack of Diversity in Simulation Technology: An Educational Limitation?

Simulation in healthcare : journal of the Society for Simulation in Healthcare·2020

Related Experiment Video

Updated: Aug 11, 2025

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

3.0K

Polycystic Ovarian Syndrome.

Sneha Shrivastava1, Rosemarie L Conigliaro2

  • 1Donald and Barbara Zucker School of Medicine/Northwell, 256-11 Union Turnpike, Glen Oaks, NY 11004, USA.

The Medical Clinics of North America
|February 9, 2023
PubMed
Summary

Polycystic ovarian syndrome (PCOS) is a complex metabolic disorder. Diagnosis uses Rotterdam criteria, with lifestyle changes as primary treatment, addressing symptoms and associated conditions like diabetes and obesity.

Keywords:
Abnormal uterine bleedingHyperandrogenismInfertilityMetabolic syndromeOligo/amenorrheaPolycystic

More Related Videos

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
04:49

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome

Published on: July 5, 2024

1.1K
A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
08:20

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

11.3K

Related Experiment Videos

Last Updated: Aug 11, 2025

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

3.0K
Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
04:49

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome

Published on: July 5, 2024

1.1K
A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
08:20

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

11.3K

Area of Science:

  • Endocrinology
  • Metabolic Disorders
  • Reproductive Health

Background:

  • Polycystic ovarian syndrome (PCOS) is a prevalent, multifactorial endocrine disorder.
  • It presents as a complex interplay of genetic and metabolic factors.
  • PCOS diagnosis commonly relies on the Rotterdam criteria.

Purpose of the Study:

  • To outline the diagnostic criteria for PCOS.
  • To detail the first-line and patient-specific treatment strategies.
  • To emphasize the importance of managing comorbid conditions associated with PCOS.

Main Methods:

  • Diagnosis based on established Rotterdam criteria.
  • Treatment approach prioritizing lifestyle modifications.
  • Symptomatic and comorbidity management tailored to patient goals.

Main Results:

  • Lifestyle changes are the cornerstone of PCOS management.
  • Treatment for menstrual irregularities and hirsutism is individualized.
  • Screening and management of comorbidities are crucial for comprehensive care.

Conclusions:

  • PCOS requires a holistic management approach.
  • Addressing symptoms and associated health risks is vital.
  • Integrated care improves patient outcomes in PCOS.